Xinhua Zhang

10PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 03, 2026
Differential [18F]FAPI-42 and [18F]FDG uptake patterns distinguish desmoid tumours from GISTs on PET/CT imaging.

Chunhui Wu, Xiaoyan Wang, Xiaojie Lin

|Dec 09, 2025
Long-term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial.

Jun Zhang, Yanqiao Zhang, Haibo Qiu

|Dec 09, 2025
Integrating surgery and targeted therapies in the management of recurrent/metastatic gastrointestinal stromal tumors.

Miao Yan, Xinhua Zhang, Mingzhe Li

|Jul 01, 2025
The management of imatinib-associated severe skin rash in gastrointestinal stromal tumor: desensitization therapy and pharmacogenetic investigation.

Xiaoman Liu, Mengying Pi, Mukai Chen

|Dec 09, 2023
Comment on Golčić et al. Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours. Cancers 2023, 15, 4081.

Anni Chen, Xinhua Zhang

|Nov 30, 2023
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies.

Michael C Heinrich, Xinhua Zhang, Robin L Jones

Pageof 2

Frequent Collaborators

2 joint publications

Yongjian Zhou

2 joint publications

Yanzhe Xia

2 joint publications

Jian Li

1 joint publications

Michael C Heinrich